TrueLab TrueLab Care
Evidence reviews · DOI-cited sources · research use only
Basics 14 Sep 2026 · 3 min read · 3 sources

Why 10 mg of peptide is not 10 mg of peptide

The number on the label is a mass of material, not a mass of compound. Between the counter-ion left by purification and the water a lyophilised powder holds, a meaningful fraction of what you weigh out is not the molecule you are studying. Here is how large that fraction is and how to account for it.

TL

TrueLab Research Team

Reviewed 14 Sep 2026 · Summarises peer-reviewed literature · Not medical advice

Key takeaways

  • Peptides purified by reversed-phase chromatography leave the column as salts of the acid used in the mobile phase, most often trifluoroacetate (TFA)[^1].
  • Counter-ions bind to basic residues. A peptide with several lysines or arginines carries several TFA molecules, each adding 114 g/mol.
  • Lyophilised peptide is hygroscopic; residual and adsorbed water commonly accounts for several percent of mass and rises once a vial has been opened at room temperature[^2].
  • TFA is not inert in cell culture: residual trifluoroacetate has measurable biological effects, which is why acetate exchange is standard for sensitive work[^3].
  • “Peptide content” is the number that answers this, and it is usually absent from research-grade certificates.

A vial says 10 mg. You dissolve it in 2 mL and record a 5 mg/mL stock. That number is almost certainly wrong, and the size of the error is not trivial.

Where the salt comes from

Reversed-phase purification runs in an acidic mobile phase, conventionally containing trifluoroacetic acid. TFA improves peak shape and resolution, which is why it became standard.

It also does something less convenient: it pairs with every positively charged group on the peptide. When the fractions are dried, those pairs stay. The peptide leaves the process as its trifluoroacetate salt, and TFA removal is a deliberate extra step requiring its own optimisation1.

The arithmetic

Trifluoroacetate has a molecular weight of about 114. Each basic site, lysine, arginine, histidine to a degree, plus the free N-terminus, can carry one.

Take a peptide of nominal mass 1400 with three basic sites. Fully associated, the salt weighs roughly 1400 + 3×114 ≈ 1742. The peptide is therefore about 80% of the salt mass before any water is considered.

The worked example: nominal mass 1400, three basic sites

Share of the dried salt's mass, before residual water is counted

Peptide ≈80%, 1400 Trifluoroacetate ≈20%, 3 × 114

Arithmetic from the text: 1400 + 3 × 114 ≈ 1742. Chart by TrueLab Care.

Now add moisture. Lyophilised solids are hygroscopic by construction, freeze-drying leaves a porous cake with enormous surface area, and residual moisture is a standard formulation concern2. A few percent is normal; more is easy to acquire if a cold vial is opened in humid air.

Combine the two and 10 mg of material can plausibly contain 7-8 mg of peptide. For a screening experiment that may not matter. For anything where molar concentration is the independent variable, a 20-30% error in the stock is not acceptable.

Why the choice of counter-ion also matters biologically

It would be convenient if the salt were merely dead weight. It is not always.

Residual trifluoroacetate carried into cell culture inhibited proliferation of osteoblasts and chondrocytes in a study specifically examining it as a contaminant of purified proteins3. The effect was attributable to the counter-ion rather than the protein.

This is the practical reason peptide intended for cell work is often supplied as the acetate salt: acetate is a normal metabolite and far less likely to produce an artefact. Acetate exchange is an additional processing step, which is part of why acetate-form material costs more.

Trifluoroacetate or acetate, the choice is not cosmetic

Why material intended for cell work is usually supplied as the acetate

Trifluoroacetate (TFA)

  • Comes free with reversed-phase purification
  • Residual TFA inhibited osteoblast and chondrocyte proliferation in culture[3]
  • Belongs on the suspect list before the peptide does

Acetate

  • Requires a deliberate exchange step, which is part of why it costs more
  • A normal metabolite, far less likely to produce an artefact

If a preparation produces an unexpected inhibition in culture, the counter-ion belongs on the list of suspects before the peptide does.

The number that resolves it

Peptide content, sometimes called net peptide content, is the fraction of the vial's mass that is peptide. It is determined by amino acid analysis after hydrolysis, or by elemental nitrogen determination, and reported as a percentage.

With it, the calculation is straightforward: 10 mg of material at 78% peptide content is 7.8 mg of peptide, and your 2 mL stock is 3.9 mg/mL rather than 5.

Without it, you are estimating. A reasonable estimate is better than none, and the estimate is bounded: identify the basic residues in the sequence, assume they are salted, assume a few percent water.

What to do in practice

  • Check the certificate for a salt form. "TFA salt" or "acetate salt" changes the mass calculation. Its absence is itself information.
  • Do not treat net mass as molar amount in any protocol where concentration is the variable being tested.
  • Weigh into the buffer, not the other way round, when working with small amounts, transferring a weighed powder loses material to static and to the vessel.
  • Store closed and cold, warm before opening. Every opening at room temperature is an opportunity for the powder to gain water, which shifts the mass fraction further.

None of this is a defect in the material. It is what a purified synthetic peptide is: a salt of an organic acid, holding some water, at a purity that a chromatogram describes and a mass measurement confirms. The label states the mass in the vial, and the rest is arithmetic you have to do.

References

  1. 1. Andrushchenko VV, Vogel HJ, Prenner EJ. Optimization of the hydrochloric acid concentration used for trifluoroacetate removal from synthetic peptides. Journal of Peptide Science 2007 ; 13(1):37-43 doi:10.1002/psc.793 ↩
  2. 2. Wang W. Lyophilization and development of solid protein pharmaceuticals. International Journal of Pharmaceutics 2000 ; 203(1-2):1-60 doi:10.1016/S0378-5173(00)00423-3 ↩
  3. 3. Cornish J, Callon KE, Lin CQ, et al. Trifluoroacetate, a contaminant in purified proteins, inhibits proliferation of osteoblasts and chondrocytes. American Journal of Physiology 1999 ; 277(5):E779, E783 doi:10.1152/ajpendo.1999.277.5.E779 ↩

This article summarises published research for educational purposes. It is not medical advice and does not describe permitted uses of any product. Compounds discussed are supplied strictly for in-vitro laboratory research and are not for human or animal consumption.

Continue reading

All The Lab →